AVDL
Price
$14.21
Change
-$0.26 (-1.80%)
Updated
Oct 8 closing price
Capitalization
1.38B
27 days until earnings call
RMTI
Price
$1.21
Change
+$0.02 (+1.68%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
41.66M
40 days until earnings call
Interact to see
Advertisement

AVDL vs RMTI

Header iconAVDL vs RMTI Comparison
Open Charts AVDL vs RMTIBanner chart's image
Avadel Pharmaceuticals
Price$14.21
Change-$0.26 (-1.80%)
Volume$1.39M
Capitalization1.38B
Rockwell Medical
Price$1.21
Change+$0.02 (+1.68%)
Volume$1.87K
Capitalization41.66M
AVDL vs RMTI Comparison Chart in %
AVDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVDL vs. RMTI commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVDL is a Hold and RMTI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (AVDL: $14.21 vs. RMTI: $1.21)
Brand notoriety: AVDL: Notable vs. RMTI: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AVDL: 84% vs. RMTI: 31%
Market capitalization -- AVDL: $1.38B vs. RMTI: $41.66M
AVDL [@Pharmaceuticals: Generic] is valued at $1.38B. RMTI’s [@Pharmaceuticals: Generic] market capitalization is $41.66M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVDL’s FA Score shows that 0 FA rating(s) are green whileRMTI’s FA Score has 0 green FA rating(s).

  • AVDL’s FA Score: 0 green, 5 red.
  • RMTI’s FA Score: 0 green, 5 red.
According to our system of comparison, AVDL is a better buy in the long-term than RMTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVDL’s TA Score shows that 4 TA indicator(s) are bullish while RMTI’s TA Score has 3 bullish TA indicator(s).

  • AVDL’s TA Score: 4 bullish, 3 bearish.
  • RMTI’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, AVDL is a better buy in the short-term than RMTI.

Price Growth

AVDL (@Pharmaceuticals: Generic) experienced а -5.27% price change this week, while RMTI (@Pharmaceuticals: Generic) price change was +1.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.16%. For the same industry, the average monthly price growth was +5.42%, and the average quarterly price growth was +62.58%.

Reported Earning Dates

AVDL is expected to report earnings on Nov 05, 2025.

RMTI is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVDL($1.38B) has a higher market cap than RMTI($41.7M). AVDL YTD gains are higher at: 35.205 vs. RMTI (-40.686). AVDL has higher annual earnings (EBITDA): 7.87M vs. RMTI (1.23M). AVDL has more cash in the bank: 81.5M vs. RMTI (18.4M). AVDL has less debt than RMTI: AVDL (2.73M) vs RMTI (14M). AVDL has higher revenues than RMTI: AVDL (221M) vs RMTI (88M).
AVDLRMTIAVDL / RMTI
Capitalization1.38B41.7M3,309%
EBITDA7.87M1.23M638%
Gain YTD35.205-40.686-87%
P/E RatioN/AN/A-
Revenue221M88M251%
Total Cash81.5M18.4M443%
Total Debt2.73M14M19%
FUNDAMENTALS RATINGS
AVDL vs RMTI: Fundamental Ratings
AVDL
RMTI
OUTLOOK RATING
1..100
5662
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
46
Fair valued
PROFIT vs RISK RATING
1..100
55100
SMR RATING
1..100
9394
PRICE GROWTH RATING
1..100
4064
P/E GROWTH RATING
1..100
45100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMTI's Valuation (46) in the Medical Specialties industry is somewhat better than the same rating for AVDL (81). This means that RMTI’s stock grew somewhat faster than AVDL’s over the last 12 months.

AVDL's Profit vs Risk Rating (55) in the Medical Specialties industry is somewhat better than the same rating for RMTI (100). This means that AVDL’s stock grew somewhat faster than RMTI’s over the last 12 months.

AVDL's SMR Rating (93) in the Medical Specialties industry is in the same range as RMTI (94). This means that AVDL’s stock grew similarly to RMTI’s over the last 12 months.

AVDL's Price Growth Rating (40) in the Medical Specialties industry is in the same range as RMTI (64). This means that AVDL’s stock grew similarly to RMTI’s over the last 12 months.

AVDL's P/E Growth Rating (45) in the Medical Specialties industry is somewhat better than the same rating for RMTI (100). This means that AVDL’s stock grew somewhat faster than RMTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVDLRMTI
RSI
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 21 days ago
85%
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
AVDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APWC1.960.03
+1.55%
Asia Pacific Wire & Cable Corp Ltd
LPX90.310.41
+0.46%
Louisiana-Pacific Corp
RNGR13.210.04
+0.30%
Ranger Energy Services
NMM44.65-0.14
-0.31%
Navios Maritime Partners LP
AMGN294.62-0.92
-0.31%
Amgen

RMTI and

Correlation & Price change

A.I.dvisor tells us that RMTI and AVDL have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RMTI and AVDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMTI
1D Price
Change %
RMTI100%
+1.68%
AVDL - RMTI
32%
Poorly correlated
-1.80%
EVOK - RMTI
29%
Poorly correlated
+1.06%
SNDL - RMTI
29%
Poorly correlated
-0.75%
HROW - RMTI
28%
Poorly correlated
-5.14%
EBS - RMTI
27%
Poorly correlated
-0.30%
More